practice logo

SUSAN JONES KALOTA, M.D.
Urology

EDUCATION

1975-1980 University of California San Diego - B.S. Major in Biology
7/77-6/78 Junior Year Education Abroad Program: Pau & Paris, France
1982-1986 Howard University College of Medicine - Washington, D.C.
1986-1988 Surgery Internship, Residency and Pre-Urology training - University of California San Diego
1988-1992 Urology Residency - University of California San Diego
10/1990 Observer at Institute of Urology - London, England

CERTIFICATES AND LICENSES:

11/1989 Lasers in Urologic Surgery - American Urologic Association - University of Pennsylvania, PA
1992 Arizona License: 20774
1992 Certification in Extracorporeal Shock Wave Lithotripsy
3/1993 Laparoscopic Surgery - Urology Loma Linda University School of Medicine
2/28/94 Diplomate American Board of Urology - Cert. # 10731

HONORS, AWARDS AND APPOINTMENTS

1984 Academic Achievement Award for academic excellence during first 2 years of medical school.
1985 Nomination to AOA Medical Honor Society - Elected Vice President of Gamma Chapter of AOA.
1986 American Medical Women's Association Scholarship Achievement Citation.
1986 Merck Manual Award to student achieving highest scholastic records.
1986 Department of Surgery honorable mention for scholastic achievement in Department of Surgery.
1986 Department of Medicine honorable mention for scholastic achievement in Department of Medicine.
1986 Ralph C. Kennedy M.D. Award for highest score in Psychiatry on the National Board Exam - Part II.
1986 Graduated Howard University - College of Medicine Salute at Orian.
1999-present Medicare Urologic Consultant.
2000 Chief of Urology, El Dorado Hospital, Tucson, Arizona.
1999-present Director, Urodynamics Lab, Tucson Medical Center

EMPLOYMENT

8/92-present Private Practice - Tucson, Arizona, General Urology
7/88-6/92 Urology Resident - University of California San Diego
1/87-6/88 General Surgery Internship and Residency - University of California San Diego
6/86-1/87 Research - University of California San Diego Department of Urology. Study in vivo urea movement across treated bladder epithelium and in vitro urinary bladder transport.
1983-1985 Medical Study Tutor - Anatomy, Microbiology and Pathophysiology
6/83-9/83 Volunteer Physician's Aide at the Center for Women's Health - Los Angeles, California
6/84-9/84 Volunteer Physician's Aide at the Center for Women's Health - Los Angeles, California
1982 Quality Assurance Specialist - General Dynamics Developed Quality Assurance Instruction Manual
1981 Volunteer Research - San Diego Veteran's Administration Hospital. Study of synthetic hemoglobin.
1980-1981 Peace Corps Volunteer - Ivory Coast, West Africa. Created a well-baby clinic, started a vaccination program, taught nutrition and disease prevention.
1979-1981 Research Associate - University of California San Diego Department of Community Medicine. Study of nutrition and prenatal risk factors to pregnancy outcome.
1979 Volunteer Research - Committee for Undernourished People San Diego California. Retrospective study of prenatal health and neurologic status of 4 & 5 year olds.
6/79-9/79 Volunteer Physician's Aide at Planned Parenthood Los Angeles California

PROFESSIONAL BACKGROUND/SOCIETY MEMBERSHIP

Member, Southern Arizona Urologic Society, 1992 - present
         Secretary/Treasurer, 1993
         President, 1994
Member, Arizona Urologic Society, 1992 - present
Western Section of American Urologic Association, 1992 - present
Member, American Urologic Association, 1998 - present
Member, Health Policy Committee, 1999/2000
Member, Committee on Women's Issues in Urology, 1999/2000
Member, Practice Parameters, Guidelines and Standards Committee, 1999/2000
Member, Society of Women in Urology, 1992 - present
         Board of Directors, 1997/1998
         President-elect, 1998/1999
         President, 1999/2000
Member, Tucson Society of Women Physicians
         Founding President, 1993/1994
         Secretary/Treasurer, 1994 - present
Member, Pima County Medical Society, 1992 - present
         Board of Directors, 1996 - present
Member, Cooperative (Commplementary/Alternative) Medicine Committee, 2000
Member, Arizona Medical Association, 1999 - present
Member, ArMA Committee on Insurance Reform, 1999/2000
Member, American Medical Association, 1999 - present
Member, AOA Honor Society, 1985 Vice President Gamma Chapter

PRESENTATIONS

  1. Jones, S.M. and Parson, C.L. - Prevention of acrolein-induced bladder injury by pentosanpolysulfate. Presented at the AUA 85th Annual Meeting. New Orleans, LA, May 13-17, 1990.
  2. Jones, S.M. - The in's and out's of GU Bleeding. Presented to Southern California Chapter of the American Urologic Association Allied. San Diego, California, September 1991.
  3. Alza Pharmaceutical Speaker's Bureau, 1999 - present.
  4. Jimmie Heuga Center Staff, Lecturer, 1999 - present.
  5. Tucson Multiple Sclerosis Society Lecturer, 1999 - present.
  6. Nurse Practitioners Annual Convention, San Diego, CA, 2000.
  7. Private Practice Gynecologist on simple cystitis, San Francisco, CA, 2000.
  8. Multiple Community Presentations for Physicians and Lay Persons.

RESEARCH EXPERIENCE

  1. Lilly Research Laboratories. Duloxetine vs. Placebo in the Relief of Stress Incontinence. LY248686
  2. Alza Protocol C-98-008: An open-label study to evaluate patient acceptance and safety of OROS Oxybuynin Chloride in urge urinary incontinence.
  3. Pharmacia and Upjohn/HSAG overactive bladder follow-up study. Phase IV: Post market Quality of Life evaluation.
  4. Pharmacia and Upjohn. Protocol 583E - URO - 0084-023, Phase IIIB, open label, single arm trial in adult patients with overactive bladder, urgency, and/or urge incontinence.
  5. Abbot. Protocol Moo - 234 AUSQ. Validation study of the Abbott Urinary Symptom Questionnaire for urinary incontinence and the overactive bladder.
  6. URGE trial. Phase IV, open-label, multicenter community based trial of Estrace cream for the treatment of urogential symptoms in postmenopausal women.

PUBLISHED WORK

  1. Parsons, C.L., Boychuk, D., Jones, S.M., Hurst, R. and Callahan, H. - Bladder surface glycosaminogylcans: an epithelial permeability barrier. JUrol 143: 139-142, 1990.
  2. Jones, S.M., Parsons, C.L. and Stein, P. - Prevention of acrolein inducted bladder injury by pentosanpolysulfate. JUrol 143(4): 280A, 1990.
  3. Jones, S.M., Stein, P.C. and Parsons, C.L. - Prevention of acrolein induced bladder injury by pentosanpolysulfate. JUrol 143(1): 163-166.
  4. Jones, S.M. - The Injured Bladder. AUA Today.
  5. Jones, S.M., Greene, L.F., and Parsons, C.L. - Evaluation of the urologic patient. The Practice of Urology W.W. Norton & Co. New York, NY 1992.
  6. Bidar, M., Kalota, S.J., and Kaplan, G.W. - Infantile hypertrophic pyloric stenosis and hydronephrosis: Is there an association? JUrol 150(1) 153-155.